FDA identifies more bogus cancer drugs in U.S

(Reuters) – The U.S. Food and Drug Administration on Tuesday said it has identified a new batch of counterfeit cancer drugs distributed in the United States and is urging doctors to avoid using the products, which contain no active ingredient.

Reuters: Health News